Ongoing Disclosure Notices – Multiple
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited
Date this disclosure made:
01/03/2018
Date of last disclosure:
29/08/2017
Director or senior manager giving disclosure
Full name(s):
John Scott WOTHERSPOON
Name of listed issuer:
The a2 Milk Company Limited
Name of related body corporate (if applicable):
Position held in listed issuer:
Chief Executive UK and Europe
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
(1) Unlisted options to subscribe for Ordinary
Shares in the Company; (2)-(5) Ordinary Shares
Nature of the affected relevant interest(s):
(1)-(5) Legal and beneficial owner
For that relevant interest-
Number held in class before acquisition or disposal:
(1) 3,200,998 Options; (2)-(5) 800,000 Ordinary
Shares
Number held in class after acquisition or disposal:
(1) 2,400,998 Options; (2)-(5) 400,000 Ordinary
Shares
Current registered holder(s):
John Scott Wotherspoon
Registered holder(s) once transfers are registered:
(1) John Scott Wotherspoon; (2)-(5) Unknown
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products
(if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable under the
derivative or the value of the derivative is affected by the value of the underlying financial
products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant interest
in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
5
Details of transactions requiring disclosure-
Date of transaction:
(1)-(2) 22/02/2018; (3) 23/03/2018; (4)-(5)
26/02/2018
Nature of transaction:
(1) Issue of 800,000 Ordinary Shares following
exercise of 800,000 Options; (2) On market sale
of 250,000 Ordinary Shares through broker
facilities; (3) On market sale of 1,160 Ordinary
Shares through broker facilities; (4)-(5) On market
sale of 148,840 Ordinary Shares (in aggregate)
through broker facilities
Name of any other party or parties to the transaction (if known):
Unknown
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or
disposal. If the consideration was not in cash and cannot be readily by converted into a cash
value, describe the consideration:
(1) $504,000 paid to exercise the Options; (2)
$3,200,000 receivable for on market sale of
Ordinary Shares through broker facilities; (3)
$14,906 receivable for on market sale of Ordinary
Shares through broker facilities; (4)-(5)
$1,897,392.10 receivable (in aggregate) for on
market sale of Ordinary Shares through broker
facilities
Number of financial products to which the transaction related:
(1) 800,000 Options; (2) 250,000 Ordinary
Shares; (3) 1,160 Ordinary Shares; (4)-(5)
148,840 Ordinary Shares (in aggregate)
If the issuer has a financial products trading policy that prohibits directors or senior managers
from trading during any period without written clearance (a closed period) include the following
details—
Whether relevant interests were acquired or disposed of during a closed period:
Nil
Whether prior written clearance was provided to allow the acquisition or disposal to proceed
during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products
(if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable under the
derivative or the value of the derivative is affected by the value of the underlying financial
products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant interest
in the derivative:
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is
correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
Notes
Use this form to disclose all the acquisitions and disposals by a director or senior manager of a
listed issuer, or of a related body corporate, or in specified derivatives. The disclosure must be
made within—
(a) 20 working days after the first acquisition or disposal disclosed in this notice if the
acquisitions or disposals are of a kind referred to in section 297(2)(a) of the Financial Markets
Conduct Act 2013; or
(b) in any other case, 5 trading days after the first acquisition or disposal disclosed in
this notice.
28 February 2018
---
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity The a2 Milk Company Limited
ABN 97 769 415 292
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
Geoffrey Babidge
Date of last notice
29 August 2017
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
Geoffrey Babidge’s relevant interest is held on
trust by GCAA Investments Pty Ltd.
Date of change
For (1), (2) and (3) 22 February 2018;
For (4) 23 February 2018;
For (5) 26 February 2018.
No. of securities held prior to change
4,000,000 partly paid ordinary shares.
Class
Fully paid ordinary shares and partly paid
ordinary shares.
Number acquired
2,000,000 fully paid ordinary shares.
Number disposed
1. 2,000,000 partly paid ordinary shares (by
virtue of payment up of those ordinary
shares in full) – the resultant 2,000,000
fully paid ordinary shares are those
referred to in (2) to (5) immediately
below.
2. 500,000 fully paid ordinary shares.
3. 500,000 fully paid ordinary shares.
4. 300,000 fully paid ordinary shares.
5. 200,000 fully paid ordinary shares.
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
1. NZ$ 1,267,200 paid up on the partly paid
ordinary shares.
2. NZ$6,800,000 (sale price for on market
sale of 500,000 ordinary shares).
3. NZ$6,477,676 (sale price for on market
sale of 500,000 ordinary shares).
4. NZ$3,888,690 (sale price for on market
sale of 300,000 ordinary shares).
5. NZ$2,563,100 (sale price for on market sale
of 200,000 ordinary shares).
No. of securities held after change
1. 2,000,000 partly paid ordinary shares.
2. 500,000 fully paid ordinary shares.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-back
1. Full payment of 2,000,000 partly paid
ordinary shares.
2. Sale of 500,000 ordinary shares on market
through broker facilities.
3. Sale of 500,000 ordinary shares on market
through broker facilities.
4. Sale of 300,000 ordinary shares on market
through broker facilities.
5. Sale of 200,000 ordinary shares on market
through broker facilities.
The share transactions are to maintain a
balanced overall investment portfolio. Mr
Babidge is to retire from his CEO role in July
2018.
As noted elsewhere on this form, Mr Babidge
continues to hold a relevant interest in
500,000 fully paid ordinary shares and
2,000,000 partly paid ordinary shares.
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
n/a
Nature of interest
n/a
Name of registered holder
(if issued securities)
n/a
Date of change
n/a
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
n/a
Interest acquired
n/a
Interest disposed
n/a
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
n/a
Interest after change
n/a
Part 3 –
+
Closed period
Were the interests in the securities or contracts detailed
above traded during a
+
closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
n/a
If prior written clearance was provided, on what date was
this provided?
n/a
---
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity The a2 Milk Company Limited
ABN 97 769 415 292
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
Peter Hinton
Date of last notice
29 August 2017
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
N/A
Date of change
For (1) and (2) 23 February 2019;
For (3), (4), (5) and (6) 26 February 2018;
For (7) 27 February 2018
No. of securities held prior to change
775,000
Class
Fully paid ordinary shares
Number acquired
Nil
Number disposed
1. 75,000 fully paid ordinary shares.
2. 5,000 fully paid ordinary shares.
3. 15,000 fully paid ordinary shares.
4. 3,170 fully paid ordinary shares.
5. 1,000 fully paid ordinary shares.
6. 830 fully paid ordinary shares.
7. 25,000 fully paid ordinary shares.
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
1. NZ$972,742.50 sale price for 75,000
ordinary shares.
2. NZ$63,950 sale price for 5,000 ordinary
shares.
3. NZ$192,000 sale price for 15,000 ordinary
shares.
4. NZ$40,734.50 sale price for 3,170 ordinary
shares.
5. NZ$12,870 sale price for 1,000 ordinary
shares.
6. NZ$10,707 sale price for 830 ordinary
shares.
7. NZ$329,000 sale price for 25,000 ordinary
shares.
No. of securities held after change
650,000 fully paid ordinary shares
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-back
1. Sale of 75,000 ordinary shares on market
through broker facilities.
2. Sale of 5,000 ordinary shares on market
through broker facilities.
3. Sale of 15,000 ordinary shares on market
through broker facilities.
4. Sale of 3,170 ordinary shares on market
through broker facilities.
5. Sale of 1,000 ordinary shares on market
through broker facilities.
6. Sale of 830 ordinary shares on market
through broker facilities.
7. Sale of 25,000 ordinary shares on market
through broker facilities.
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
n/a
Nature of interest
n/a
Name of registered holder
(if issued securities)
n/a
Date of change
n/a
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
n/a
Interest acquired
n/a
Interest disposed
n/a
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
n/a
Interest after change
n/a
Part 3 –
+
Closed period
Were the interests in the securities or contracts detailed
above traded during a
+
closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
n/a
If prior written clearance was provided, on what date was
this provided?
n/a
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- NZX — NZX Limited: D&O Ongoing Disclosure – Jon Macdonald2017-12-21
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: NZX Limited Date this disclosure made: 22-Dec-17 Date of last disclosure: 4-Sep-1…”
- NZX — NZX Limited: D&O Ongoing Disclosures – Multiple2018-04-04
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: NZX Limited Date this disclosure made:4-Apr-18 Date of last disclosure: 22-May-17 D…”
- OCA — Oceania Healthcare Limited: D&O Ongoing Disclosures – Multiple2018-01-25
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and ASX Name of listed issuer: Oceania Healthcare Limited Date this disclosure made: 26-Jan-18 Date of last di…”